This company listing is no longer active
Acasti Pharma Management
Management criteria checks 0/4
Key information
Jan D'Alvise
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 25.1% |
| CEO tenure | 6.8yrs |
| CEO ownership | 0.01% |
| Management average tenure | 1.6yrs |
| Board average tenure | 1.4yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -US$17m |
| Sep 30 2022 | n/a | n/a | -US$17m |
| Jun 30 2022 | n/a | n/a | -US$11m |
| Mar 31 2022 | US$2m | US$445k | -US$10m |
| Dec 31 2021 | n/a | n/a | -US$12m |
| Sep 30 2021 | n/a | n/a | -US$11m |
| Jun 30 2021 | n/a | n/a | -US$18m |
| Mar 31 2021 | US$582k | US$428k | -US$20m |
| Dec 31 2020 | n/a | n/a | US$3m |
| Sep 30 2020 | n/a | n/a | -US$6m |
| Jun 30 2020 | n/a | n/a | -US$21m |
| Mar 31 2020 | US$2m | US$411k | -US$26m |
| Dec 31 2019 | n/a | n/a | -US$56m |
| Sep 30 2019 | n/a | n/a | -US$46m |
| Jun 30 2019 | n/a | n/a | -US$42m |
| Mar 31 2019 | US$926k | US$373k | -US$39m |
| Dec 31 2018 | n/a | n/a | -US$31m |
| Sep 30 2018 | n/a | n/a | -US$34m |
| Jun 30 2018 | n/a | n/a | -US$20m |
| Mar 31 2018 | US$891k | US$337k | -US$17m |
| Mar 31 2017 | US$631k | US$275k | -US$8m |
Compensation vs Market: Jan's total compensation ($USD1.77M) is above average for companies of similar size in the Canadian market ($USD172.33K).
Compensation vs Earnings: Jan's compensation has increased whilst the company is unprofitable.
CEO
Jan D'Alvise (67 yo)
6.8yrs
Tenure
US$1,773,841
Compensation
Ms. Janelle D’Alvise, also known as Jan, has been an Independent Director of Spectral Medical Inc. since June 03, 2021. She is the Chairman of the board of The ObG Project. She has been the Chief Executive...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.8yrs | US$1.77m | 0.015% $ 2.8k | |
| Co-Founder | 12.9yrs | US$905.45k | 0.0020% $ 377.0 | |
| Chief Financial Officer | 2.5yrs | US$847.55k | 0% $ 0 | |
| Chief Operating Officer of US | 1.6yrs | US$666.86k | 0% $ 0 | |
| Chief Commercial Officer | 1.2yrs | US$403.62k | 0.29% $ 55.2k | |
| Vice President of Quality & Compliance | 1.5yrs | no data | no data | |
| Senior Director of Human Resources | 1.2yrs | no data | no data |
1.6yrs
Average Tenure
61yo
Average Age
Experienced Management: ACST's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.7yrs | US$1.77m | 0.015% $ 2.8k | |
| Independent Director | 4.9yrs | US$131.60k | 0.011% $ 2.0k | |
| Independent Director | less than a year | US$6.00k | no data | |
| Independent Director | 6.7yrs | US$134.10k | 0.028% $ 5.4k | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | 1.6yrs | US$96.60k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | 1.2yrs | no data | no data |
1.4yrs
Average Tenure
61yo
Average Age
Experienced Board: ACST's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.